−0.406 EUR
−8.66 M EUR
3.25 M EUR
15.73 M
About GLOBALBIOENERGIES
Sector
CEO
Marc Delcourt
Headquarters
Evry
Website
Founded
2008
ISIN
FR0011052257
FIGI
BBG001QG0CY9
Global Bioenergies SA develops industrial processes to convert renewable sources into isobutene. The company was founded by Marc Delcourt and Philippe Marlière on October 6, 2008 and is headquartered in Evry, France.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ALGBE is 0.810 EUR — it has decreased by −1.16% in the past 24 hours. Watch GLOBALBIOENERGIES stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange GLOBALBIOENERGIES stocks are traded under the ticker ALGBE.
ALGBE stock has fallen by −14.35% compared to the previous week, the month change is a −33.04% fall, over the last year GLOBALBIOENERGIES has showed a −61.43% decrease.
ALGBE reached its all-time high on May 26, 2015 with the price of 58.913 EUR, and its all-time low was 0.432 EUR and was reached on Oct 17, 2024. View more price dynamics on ALGBE chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ALGBE stock is 7.66% volatile and has beta coefficient of 0.03. Track GLOBALBIOENERGIES stock price on the chart and check out the list of the most volatile stocks — is GLOBALBIOENERGIES there?
Today GLOBALBIOENERGIES has the market capitalization of 14.10 M, it has decreased by −13.44% over the last week.
Yes, you can track GLOBALBIOENERGIES financials in yearly and quarterly reports right on TradingView.
ALGBE net income for the last half-year is −2.79 M EUR, while the previous report showed −4.57 M EUR of net income which accounts for 38.99% change. Track more GLOBALBIOENERGIES financial stats to get the full picture.
No, ALGBE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 22, 2024, the company has 46.00 employees. See our rating of the largest employees — is GLOBALBIOENERGIES on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GLOBALBIOENERGIES EBITDA is −11.37 M EUR, and current EBITDA margin is −331.18%. See more stats in GLOBALBIOENERGIES financial statements.
Like other stocks, ALGBE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GLOBALBIOENERGIES stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GLOBALBIOENERGIES technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GLOBALBIOENERGIES stock shows the sell signal. See more of GLOBALBIOENERGIES technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.